![]() |
Volumn 29, Issue 23, 2011, Pages
|
Rare phenomenon: Liver metastases from glioblastoma multiforme
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BEVACIZUMAB;
CYTARABINE;
FENTANYL;
GLIAL FIBRILLARY ACIDIC PROTEIN;
KI 67 ANTIGEN;
LORAZEPAM;
MICROTUBULE ASSOCIATED PROTEIN 2;
PROTEIN S 100;
TEMOZOLOMIDE;
AGED;
AGGRESSIVENESS;
AGITATION;
ALKALINE PHOSPHATASE BLOOD LEVEL;
ARTICLE;
ATELECTASIS;
AUTOPSY;
CANCER CHEMOTHERAPY;
CANCER GRADING;
CANCER RADIOTHERAPY;
CANCER RELAPSE;
CANCER SURGERY;
CASE REPORT;
DISEASE COURSE;
DRUG SUBSTITUTION;
DRUG WITHDRAWAL;
DYSARTHRIA;
FRONTAL LOBE;
GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL;
GLIOBLASTOMA;
HEART RIGHT VENTRICLE FAILURE;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
IMMUNOPATHOLOGY;
INTRATHECAL DRUG ADMINISTRATION;
LACTATE DEHYDROGENASE BLOOD LEVEL;
LIVER EXAMINATION;
LIVER FAILURE;
LIVER METASTASIS;
LIVER NECROSIS;
MALE;
MORTALITY;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PRIORITY JOURNAL;
SIDE EFFECT;
SPEECH DISORDER;
TUMOR CELL;
ULTRASOUND;
AGED;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
BRAIN NEOPLASMS;
COMBINED MODALITY THERAPY;
DACARBAZINE;
GLIOBLASTOMA;
HUMANS;
IMMUNOHISTOCHEMISTRY;
LIVER NEOPLASMS;
MALE;
RADIOTHERAPY;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 80051804871
PISSN: 0732183X
EISSN: 15277755
Source Type: Journal
DOI: 10.1200/JCO.2011.35.9232 Document Type: Article |
Times cited : (23)
|
References (5)
|